BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Liver cancer

1. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. HLF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. HNF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. ALDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. CEBPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. MPL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. RPL22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. DNAJB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. SEPT5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. SFPQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. TBX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. COL2A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. GNAQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. FOXA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. ARID2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. DDX3X
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. TFE3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. LEF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. PPARG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. CANT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. GNA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. MITF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. CNBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. PER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. PRKACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. SS18
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. APOBEC3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. ATF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. DDX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. FOXO4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. LIFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. MECOM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. MSN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. PBRM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. PIK3R1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. RALGDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. TRIM24
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. BMPR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. EML4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [